Kimberly Maersk-Moller - 28 Feb 2025 Form 4 Insider Report for MIMEDX GROUP, INC. (MDXG)

Role: Chief Commercial Officer
Signature: /s/ William F. Hulse, as attorney-in-fact for Kimberly Maersk-Moller
Issuer symbol: MDXG
Transactions as of: 28 Feb 2025
Net transactions value: -$17,743
Form type: 4
Filing time: 05 Mar 2025, 19:13:28 UTC
Previous filing: 13 Dec 2024
Next filing: 14 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDXG	Common Stock	Sale	$17,743	-2,111	-0.79%	$8.40	265,271	28 Feb 2025	Direct	F1
transaction	MDXG	Common Stock	Award	$0	+45,929	+17%	$0.000000	314,942	03 Mar 2025	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MDXG	Stock Options	Award	$0	+36,486	+93%	$0.000000	75,794	03 Mar 2025	Common Stock	36,486	$8.30	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, in accordance with company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.
F2	Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.
F3	Includes an aggregate of 3,742 shares acquired on July 31, 2024 and January 31, 2025 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan.
F4	The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.